logo

Divi's Laboratories Ltd. Financials

15:56 Jul 31

Divi's Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
6595.50
-54.50 (-0.82%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Divi's Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
6595.50
-54.50 (-0.82%)
15:56 Jul 31
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

27/100
Expensive Valuation

Technical

52/100
Technically Neutral

Strength

7

Weakness

3

Opportunity

1

Threats

0

14.63 %

ROE %

12.93 %

ROA %

82.53

EPS

564.87

BVPS

23.40 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
6969.4 8959.83 7767.51 7845 9360
Operating Expenses +
4109.46 5077.89 5399.69 5640 6392
Raw Material
2402.75 3490.97 3030.69 3238 3821
Increase Decrease in Cost
-78.67 -523.83 23.03 -109 -96
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
825.76 946.16 975.02 1094 1243
Miscellaneous Expenses
970.24 1193.41 1415.61 1429 1424
Operating Profit
2859.94 3881.94 2367.82 2205 2968
Other Income
62.56 113.87 344.66 339 352
Depreciation
255.59 311.51 343.18 378 402
Interest
0.87 0.8 0.67 3 2
Profit before tax and exceptio..
2666.04 3683.5 2368.63 2163 2916
Exceptional Items
0 0 0 0 0
PBT
2666.04 3683.5 2368.63 2163 2916
Provision for Taxation
681.75 723.05 545.25 563 725
Net Profit
1984.29 2960.45 1823.38 1600 2191
NET Profit after MI
1984.29 2960.45 1823.38 1600 2191
EPS
74.75 111.52 68.69 60.27 82.53
Operating Profit Margin (%)
41.04 43.33 30.48 28.11 31.71
Net Profit Margin (%)
28.47 33.04 23.47 20.4 23.41

Divi's Laboratories Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Jun 25 Mar 25 Dec 24 Sep 24 Jun 24
Promoter 51.90 51.90 51.90 51.90 51.90
FII 19.70 18.00 18.00 17.20 16.20
MF 13.30 12.80 11.90 11.90 13.10
Others 5.80 7.90 8.60 9.20 8.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: